News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
329 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21720)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (335)
2 (389)
3 (283)
4 (319)
5 (131)
6 (6)
7 (4)
8 (279)
9 (329)
10 (321)
11 (307)
12 (125)
13 (3)
14 (8)
15 (254)
16 (287)
17 (204)
18 (246)
19 (94)
20 (14)
21 (3)
22 (244)
23 (272)
24 (225)
25 (255)
26 (87)
27 (4)
28 (5)
29 (233)
30 (284)
31 (251)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Drug Development
Novartis’ Autoimmune Drug Not Up for the Challenge in Phase III Cancer Trial
The drug was being evaluated in 237 adults with locally advanced or metastatic non-small cell lung cancer whose disease progressed while on or after previous platinum-based chemotherapy and checkpoint inhibitor immunotherapy.
March 9, 2021
·
3 min read
·
Mark Terry
Genetown
New Drug Approval Could Be on Horizon for Alzheimer’s after 17-Year Drought
A drug to halt the progression of Alzheimer’s disease will likely be approved within the next three years, and Alzheon’s ALZ-801 might be the leading candidate.
March 9, 2021
·
5 min read
·
Gail Dutton
Business
New CDC Guidance for Fully Vaccinated People Brings Hope (and Criticism)
In the wake of an increasingly accelerated COVID-19 vaccine rollout, the CDC has released new guidance statements that give fully vaccinated individuals more freedom to socialize and participate in pre-pandemic activities.
March 9, 2021
·
3 min read
·
Brandon May
Business
Takeda Inks Deal to Go After Solid Tumors with Maverick T-Cell Engager Technology
The pair’s lead candidate, TAK-186 (formerly MVC-101), a first-in-class conditionally active T-cell engager, has recently entered the clinic in a Phase I/II study for the treatment of EGFR-expressing solid tumors such as those found in head and neck cancers.
March 9, 2021
·
3 min read
·
Heather McKenzie
Job Trends
Top 10 Most Expensive Drugs on the Market
Prescription drug watchdog GoodRx compiled a list of the 10 most expensive drugs on the market. Read further to know more about which drugs are on the list.
March 9, 2021
·
2 min read
·
Alex Keown
Drug Development
2021 Biopharma Update on the Novel Coronavirus: March 9
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 9, 2021.
March 9, 2021
·
5 min read
·
BioSpace Editorial Staff
Electrophysiology Market: Top 8 trends boosting the industry demand through 2027
Driven by the growing focus toward the management of cardiac arrhythmias and the rising acclaim for telemedicine in the wake of the COVID-19 pandemic, the demand for noninvasive and invasive electrophysiology procedures is expected to soar rapidly throughout the globe.
March 9, 2021
·
7 min read
CARB-X Places $22 Million Bet on Affinivax Staph Vaccine
Less than two months after bacterial vaccine company Affinivax’s Series C financing, the company is getting a $22 million boost from infectious disease consortium CARB-X to push forward a vaccine for tough-to-treat preclinical Staphylococcus aureus
March 9, 2021
·
2 min read
·
Mark Zipkin
Business
Industry Veterans Jump Ship in Favor of Smaller Biotechs
It didn’t take long for Jason Campagna to find a new role after departing Intercept Pharmaceuticals last month. Campagna will take on the role of chief medical officer for Q32 Bio.
March 9, 2021
·
3 min read
·
Alex Keown
Business
Promoting Diversity & Inclusion Through an Ethos of Cultural and Emotional Intelligence
Despite a historic push for greater diversity and inclusion (D&I), a significant disconnect prevails between good intentions and actual lived experiences.
March 9, 2021
·
6 min read
·
Heather McKenzie
1 of 33
Next